Skip to main content

Closed

BLRX: BioLineRx Ltd. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

28thpctl

Volume

0.20×avg

Market Cap

12.27MUSD

P/E Ratio

-1.5TTM

Div Yield

-ann

BioLineRx Ltd.

BLRXNASDAQ Capital Market·USD·Closed

BioLineRx Ltd.

BLRXNASDAQ·USD·Closed

$2.82

+4.44%

$2.82

+$0.12 (4.44%)

52W Range

28thpctl

Volume

0.20×avg

Mkt Cap

12.27MUSD

P/E

-1.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings